Exelixis (NASDAQ:EXEL) said on Wednesday that the U.S. FDA has approved cabozantinib for patients 12 years of age and older ...

Liver cancer, predominantly hepatocellular carcinoma (HCC), remains one of the most aggressive and leading causes of ...

A Chinese research team has developed an AI tool that predicts liver cancer recurrence risk with 82.2 percent accuracy, ...

Responding to the progress of its obesity pipeline, the Chinese biotech is stepping up its investment in metabolic disease ...

Chinese scientists and their Singaporean collaborators have developed a scoring system to predict the risk of recurrence for ...

The scoring method, called the Tumor Immune Microenvironment Spatial System ... the team of scientists published its findings ...

Karen Kennerley assumed her fatigue was from working so hard — now the mom is trying to raise money for treatment to treat ...

Histotripsy, a non-invasive procedure for liver cancer treatment, is now available in Metairie, offering hope to patients in ...

When a critical care physician suddenly needs critical care, she learns as a patient everything she wishes she’d been taught ...

General transcription factor IIIC subunit 2 (GTF3C2) is one of the polymerase III transcription-related factors. Previous studies have revealed that ...

Mar. 13, 2025 — When mothers eat a diet high in fat and sugars, their unborn babies can develop liver stress that continues into early life. A new study sheds light on changes to the fetus's ...